We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Comparison of Human and Mouse Interleukins Reveals Link

By LabMedica International staff writers
Posted on 05 Feb 2019
Print article
Image: Modified human interleukin-27-alpha. Inspired by the murine interleukin-27-alpha, one amino acid has been exchanged, enabling the formation of a disulfide-bridge (marked in red) (Photo courtesy of Dr. M. Feige, Technical University of Munich).
Image: Modified human interleukin-27-alpha. Inspired by the murine interleukin-27-alpha, one amino acid has been exchanged, enabling the formation of a disulfide-bridge (marked in red) (Photo courtesy of Dr. M. Feige, Technical University of Munich).
A study comparing the structure and function of human and mouse interleukins revealed a close link between protein folding and immune regulation.

Interleukins are small, secreted proteins that drive immune cell communication. Understanding how cells produce interleukins is considered to be critical for decoding and modulating immune responses. An example of particular complexity and biological relevance is the interleukin 12 (IL-12) family. Four functionally distinct alpha-beta heterodimers are assembled from only five subunits to regulate immune cell function and development. In addition, some subunits act as independent signaling molecules. In particular, IL-27 is composed of two subunits, alpha and beta. In humans, these have to assemble to form bioactive IL-27, whereas in mice, IL-27alpha can be secreted alone, modulating immune reactions and reducing sepsis-related mortality.

Investigators at the Technical University of Munich (Germany) reported in the January 16, 2019, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America that differences in a single amino acid determined if IL-27alpha could be secreted autonomously, acting as a signaling molecule, or if it depended on hetero-dimerization for secretion.

By combining computer simulations with biochemical experiments, the investigators dissected the underlying structural determinants: a protein folding switch coupled to disulfide bond formation regulated chaperone-mediated retention versus secretion.

Using these insights the investigators changed folding and assembly control for this protein. This provided the basis for a more human-like IL-27 system in mice and established a secretion-competent human IL-27alpha that signaled on its own and could regulate immune cell function.

"The interleukins are the vocabulary with which immune cells communicate," explained Dr. Matthias Feige, professor of cellular protein biochemistry at the Technical University of Munich. "The cells form these messenger molecules according to a very specific blueprint of individual amino acids. Their arrangement determines, which three-dimensional structure an interleukin adopts and, consequently, which information it transmits. Our approach allowed us to rationally extend the language of immune cells by engineering a key signaling molecule. This provides us with an opportunity to modulate the reaction of immune cells in a targeted manner."

Related Links:
Technical University of Munich

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit
New
FOB+Transferrin+Calprotectin+Lactoferrin Test
CerTest FOB+Transferrin+Calprotectin+Lactoferrin Combo Test

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.